High-Resolution Crystal Structure of the Subclass B3 Metallo-β-Lactamase BJP-1: Rational Basis for Substrate Specificity and Interaction with Sulfonamides
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Metallo-β-lactamases (MBLs) are important enzymatic factors in resistance to β-lactam antibiotics that show important structural and functional heterogeneity. BJP-1 is a subclass B3 MBL determinant produced by Bradyrhizobium japonicum that exhibits interesting properties. BJP-1, like CAU-1 of Caulobacter vibrioides , overall poorly recognizes β-lactam substrates and shows an unusual substrate profile compared to other MBLs. In order to understand the structural basis of these properties, the crystal structure of BJP-1 was obtained at 1.4-Å resolution. This revealed significant differences in the conformation and locations of the active-site loops, determining a rather narrow active site and the presence of a unique N-terminal helix bearing Phe-31, whose side chain binds in the active site and represents an obstacle for β-lactam substrate binding. In order to probe the potential of sulfonamides (known to inhibit various zinc-dependent enzymes) to bind in the active sites of MBLs, the structure of BJP-1 in complex with 4-nitrobenzenesulfonamide was also obtained (at 1.33-Å resolution), thereby revealing the mode of interaction of these molecules in MBLs. Interestingly, sulfonamide binding resulted in the displacement of the side chain of Phe-31 from its hydrophobic binding pocket, where the benzene ring of the molecule is now found. These data further highlight the structural diversity shown by MBLs but also provide interesting insights in the structure-function relationships of these enzymes. More importantly, we provided the first structural observation of MBL interaction with sulfonamides, which might represent an interesting scaffold for the design of MBL inhibitors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, some high potency inhibitors coordinate Zn2+ via uncharged nitrogens with electron lone pairs, such as those found in sulfonamides18 and imidazoles6 (see Figure 13), that seem to interact more strongly than negatively charged nitro groups.7”
From AutoDock4Zn: An Improved AutoDock Force Field for Small-Molecule Docking to Zinc Metalloproteins (2014) · cites this paper as [7]
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581 · cited 2×
“The stereochemical quality of both refined models was assessed using the program PROCHECK (30).”
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
Addison, A. W., Rao, T. N., Reedijk, J., van Rijn, J., & Verschoor, G. C. (1984) · J. Chem. Soc., Dalton Trans. · doi:10.1039/dt9840001349 · Cited by 9,445
MOLREP: an Automated Program for Molecular Replacement
Vagin, A., & Teplyakov, A. (1997) · Journal of Applied Crystallography · doi:10.1107/s0021889897006766 · Cited by 4,714
Knowledge‐based protein secondary structure assignment
Frishman, D., & Argos, P. (1995) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340230412 · Cited by 2,523
XtalView/Xfit—A Versatile Program for Manipulating Atomic Coordinates and Electron Density
McRee, D. E. (1999) · Journal of Structural Biology · doi:10.1006/jsbi.1999.4094 · Cited by 2,094
Use of TLS parameters to model anisotropic displacements in macromolecular refinement
Winn, M. D., Isupov, M. N., & Murshudov, G. N. (2001) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444900014736 · Cited by 1,696
The integration of macromolecular diffraction data
Leslie, A. G. W. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905039107 · Cited by 1,341
Research works printed but not linked: 2
- Basolo, F., and R. G. Pearson. 1967. Acid-base properties of complex ions, p. 31-33. InMechanisms of inorganic reactions. Wiley, New York, NY.
- Evans, P. R. 1997. SCALA, continuous scaling program. Joint CCP4 ESF-EACBM Newsl.33:22-24.
Cited by
Metallo‐β‐lactamase structure and function
Palzkill, T. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06796.x · Cited by 505
Liu, B., Trout, R. E. L., Chu, G.-H., McGarry, D., Jackson, R. W., Hamrick, J. C., Daigle, D. M., Cusick, S. M., Pozzi, C., De Luca, F., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01518 · Cited by 312
Self-citationAutoDock4Zn: An Improved AutoDock Force Field for Small-Molecule Docking to Zinc Metalloproteins
Santos-Martins, D., Forli, S., Ramos, M. J., & Olson, A. J. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500209e · Cited by 318
Bahr, G., González, L. J., & Vila, A. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00138 · Cited by 266
Jeon, J., Lee, J., Lee, J., Park, K., Karim, A., Lee, C.-R., Jeong, B., & Lee, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16059654 · Cited by 192
“The crystal structures of subclass B3 enzymes, including L1 from Stenotrophomonas maltophilia [156], FEZ-1 from Fluoribacter gormanii [157], BJP-1 from Bradyrhizobium japonicum [158], and AIM-1 from P.”
BackgroundOvercoming differences: The catalytic mechanism of metallo‐β‐lactamases
Meini, M.-R., Llarrull, L. I., & Vila, A. J. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.08.015 · Cited by 145
Kim, Y., Tesar, C., Mire, J., Jedrzejczak, R. P., Binkowski, A., Babnigg, G., Sacchettini, J. C., & Joachimiak, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024621 · Cited by 131
Metallo-β-lactamase: Inhibitors and reporter substrates
Fast, W. L., & Sutton, L. D. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.04.024 · Cited by 101
Recent research and development of NDM-1 inhibitors
Wang, T., Xu, K., Zhao, L., Tong, R., Xiong, L., & Shi, J. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113667 · Cited by 91
Carbapenem Resistance in Elizabethkingia meningoseptica Is Mediated by Metallo-β-Lactamase BlaB
González, L. J., & Vila, A. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05835-11 · Cited by 102
“Similar concerns have been raised for other B3 subclass enzymes, such as BJP-1 and CAU-1 (14, 15, 40), despite their lower catalytic efficiencies (32).”
BackgroundKazmierczak, K. M., Bradford, P. A., Stone, G. G., DeJonge, B. L. M., & Sahm, D. F. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00592-18 · Cited by 91
Evolution of Metallo-β-lactamases: Trends Revealed by Natural Diversity and in vitro Evolution
Meini, M.-R., Llarrull, L. I., & Vila, A. J. (2014) · Antibiotics · doi:10.3390/antibiotics3030285 · Cited by 98
“closely resembles that of B1 enzymes, however, the B1 Zn2 ligand Cys221 is replaced by His121 in B3 enzymes, and a third water molecule participates as a fifth ligand giving rise to a square pyramidal coordination sphere of Zn2 [48].”
BackgroundSimplified captopril analogues as NDM-1 inhibitors
Li, N., Xu, Y., Xia, Q., Bai, C., Wang, T., Wang, L., He, D. K., Xie, N., Li, L., Wang, J., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.10.068 · Cited by 90
A variety of roles for versatile zinc in metallo-β-lactamases
Karsisiotis, A. I., Damblon, C., & Roberts, G. C. K. (2014) · Metallomics · doi:10.1039/c4mt00066h · Cited by 75
Principles and current strategies targeting metallo‐β‐lactamase mediated antibacterial resistance
Yan, Y., Li, G., & Li, G. (2020) · Medicinal Research Reviews · doi:10.1002/med.21665 · Cited by 74
Hinchliffe, P., Tanner, C. A., Krismanich, A. P., Labbé, G., Goodfellow, V. J., Marrone, L., Desoky, A. Y., Calvopiña, K., Whittle, E. E., Zeng, F., et al. (2018) · Biochemistry · doi:10.1021/acs.biochem.7b01299 · Cited by 69
A close look onto structural models and primary ligands of metallo-β-lactamases
Raczynska, J. E., Shabalin, I. G., Minor, W., Wlodawer, A., & Jaskólski, M. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.08.001 · Cited by 67
“33 Å structure contains 4-nitrobenzene-sulfonamide, a potential inhibitor, bound in the active site and interacting with the Zn ions (Docquier et al., 2010).”
BackgroundSoil microbial responses to multiple global change factors as assessed by metagenomics
del Río, Á. R., Scheu, S., & Rillig, M. C. (2025) · Nature Communications · doi:10.1038/s41467-025-60390-4 · Cited by 76
“Similarly, the only inactivation gene signi fi cantlyincreasing in frequency after the 8-factor treatment was the metallo-beta lacta-mase BJP-1, characteristic of Bradyrhizobium 74 (Two-sided Wilcoxon test, p =0.009, Fig.”
InfluentialLeiros, H. S., Borra, P. S., Brandsdal, B. O., Edvardsen, K. S. W., SPENCER, J. M., Walsh, T. R., & Samuelsen, Ø. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00448-12 · Cited by 64
“Available three-dimensional (3D) structures for B3 subclass MBLs include those of L1 (Stenotrophomonas maltophilia) (53, 56) and, as inhibitor complexes (36, 43), FEZ-1 (Legionella gormanii) (23) and BJP-1 (Bradyrhizobium japonicum) (15).”
BackgroundInfluentialLeiris, S. J., Coelho, A., Castandet, J., Bayet, M., Lozano, C., Bougnon, J., Bousquet, J., Everett, M. J., Lemonnier, M., Sprynski, N., et al. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00246 · Cited by 60
Self-citationWachino, J.-I., Yamaguchi, Y., Mori, S., Kurosaki, H., Arakawa, Y., & Shibayama, K. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01264-12 · Cited by 50
4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors
Gavara, L., Sevaille, L., Luca, F. D., Mercuri, P. S., Bebrone, C., Feller, G., Legru, A., Cerboni, G., Tanfoni, S., Baud, D., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112720 · Cited by 52
“Data were processed as described elsewhere [47,48] and the structures obtained by molecular replacement using the native structure of the corresponding enzyme (PDB code 1KO3), excluding solvent and other ligands.”
Self-citationMetallo-β-Lactamases: A Major Threat to Human Health
Phelan, E. K., Miraula, M., Selleck, C., Ollis, D. L., Schenk, G., & Mitić, N. (2014) · American Journal of Molecular Biology · doi:10.4236/ajmb.2014.43011 · Cited by 43
“japonicum [77], MIM-1 from N.”
Morán-Barrio, J., Lisa, M., Larrieux, N., Drusin, S. I., Viale, A. M., Moreno, D. M., Buschiazzo, A., & Vila, A. J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01067-16 · Cited by 34
“The wide substrate-binding groove in GOB enzymes correlates with high catalytic efficiencies for a broad spectrum of substrates, in contrast to BJP-1, in which an N-terminal helix partially covers the active site (22).”
BackgroundMetallo-β-Lactamases: Structural Features, Antibiotic Recognition, Inhibition, and Inhibitor Design
Wang, J., & Chou, K. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113139990011 · Cited by 36
“According to the crystal structure studies [62-73], metallo- -lactamases (especially the B1 subgroup) shares a common / sandwich fold with two -sheets at the core and four -helices at the external faces, as shown in Fig.”
BackgroundVirtual Screening and Experimental Testing of B1 Metallo-β-lactamase Inhibitors
Kang, J. S., Zhang, A. L., Faheem, M., Zhang, C. J., Ai, N., Buynak, J. D., Welsh, W. J., & Oelschlaeger, P. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00133 · Cited by 34
Discovery of Novel New Delhi Metallo-β-Lactamases-1 Inhibitors by Multistep Virtual Screening
Wang, X., Lü, M., Shi, Y., Ou, Y., & Cheng, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118290 · Cited by 32
“The crystal structure of 4-nitrobenzenesulfonamide interacting with BJP-1, a B3 subclass MBLs, reveals that binding of sulfonamide changes coordination number and geometry for Zn1 by adding one oxygen atom of sulfonamides to the Zn2 and the nitrobenzene moiety form a hydrophobic pocket in the active site [56].”
BackgroundThe Inhibition of Extended Spectrum β-Lactamases: Hits and Leads
Farina, D. S. F., Spyrakis, F., Venturelli, A., Cross, S., Tondi, D., & Costi, M. P. (2014) · Current Medicinal Chemistry · doi:10.2174/09298673113206660323 · Cited by 25
Wachino, J.-I., Yamaguchi, Y., Mori, S., Jin, W., Kimura, K., Kurosaki, H., & Arakawa, Y. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03108-15 · Cited by 24
Valdez, C. E., Sparta, M., & Alexandrova, A. N. (2012) · Journal of Chemical Theory and Computation · doi:10.1021/ct300712j · Cited by 22
Selleck, C., Pedroso, M. M., Wilson, L. A., Krco, S., Knaven, E. G., Miraula, M., Mitić, N., Larrabee, J. A., Brück, T., Clark, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68612-z · Cited by 20
Salimraj, R., Zhang, L., Hinchliffe, P., Wellington, E. M. H., Brem, J., Schofield, C. J., Gaze, W. H., & SPENCER, J. M. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00750-16 · Cited by 20
Fragment-Based Inhibitor Discovery Against β-Lactamase
Nichols, D. A., Renslo, A. R., & Chen, Y. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.10 · Cited by 21
Characterization of the resistome in Lactobacillus genomic sequences from the human gut
Moradi, J., Fathollahi, M., Halimi, S., Alvandi, A., Abiri, R., Vaziri, S., & Rezaei, A. (2022) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2022.05.014 · Cited by 17
Bradford, P. A., Huband, M. D., & Stone, G. G. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00223-18 · Cited by 16
Rodríguez, M. M., Herman, R., Ghiglione, B., Kerff, F., González, G. D. ́., Bouillenne, F., Galleni, M., Handelsman, J., Charlier, P., Gutkind, G., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182043 · Cited by 17
Wilson, L. A., Knaven, E. G., Morris, M. T., Pedroso, M. M., Schofield, C. J., Brück, T., Mikael Bodén, A., Waite, D. W., Hugenholtz, P., Guddat, L. W., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00936-21 · Cited by 15
“A similar observation with respect to the displacement of the bridging hydroxide was made with other inhibitors of B3 MBLs, including mercaptoacetate, 4-nitrobenzenesulfonamide, and 2-mercaptoethanesulfonate (48, 51, 52).”
BackgroundAn Elusive Task: A Clinically Useful Inhibitor of Metallo-β-Lactamases
González, M. M., & Vila, A. J. (2016) · Topics in medicinal chemistry · doi:10.1007/7355_2016_6 · Cited by 10
Probing the Role of Met221 in the Unusual Metallo-β-lactamase GOB-18
Lisa, M., Morán-Barrio, J., Guindón, M.-F., & Vila, A. J. (2012) · Inorganic Chemistry · doi:10.1021/ic301801h · Cited by 9
Shabbir, F., Mishra, V. K., Noor, S., Nath, S., Khan, M. U., Fawy, K. F., Nishan, U., Dib, H., Shah, M., & Chen, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-12523-4 · Cited by 7
Binding site residues in β-lactamases: role in non-classical interactions and metal binding
Lavanya, P., Ramaiah, S., & Anbarasu, A. (2014) · Journal of Coordination Chemistry · doi:10.1080/00958972.2014.956661 · Cited by 6
Pisa, F. D., Pozzi, C., Benvenuti, M., Docquier, J., Luca, F. D., & Mangani, S. (2017) · Inorganica Chimica Acta · doi:10.1016/j.ica.2017.07.030 · Cited by 6
Self-citationAu, S. X., Padzil, A. M., Noor, N. D. M., Matsumura, H., Rahman, R. N. Z. R. A., & Normi, Y. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291012 · Cited by 7
Wachino, J.-I., Yamaguchi, Y., Mori, S., Yamagata, Y., Arakawa, Y., & Shibayama, K. (2012) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309112004691 · Cited by 5
“In addition, the crystal structures of subclass B3 MBLs in complex with inhibitory agents have been reported, including L1– d-captopril (Nauton et al., 2008) and BJP-1–4-nitrobenzenesulfonamide (Docquier et al., 2010).”
BackgroundWang, L., Yang, L., Feng, Y., & Zhang, H. (2020) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-020-01822-y · Cited by 4
Alotaibi, B. S., Shabbir, F., Khan, M. U., Ahmad, I., Khalid, H., Aziz, S., Ali, A., Younas, S., Dib, H., Fawy, K. F., et al. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10801-1 · Cited by 3
“Although several compounds such as sulfonamides, boric acid derivatives [7], captopril, thiol-containing small molecules [8], aspergillomarasmine A [9], and various natural products have been reported to inhibit NDM-1 activity, none have been approved for clinical use due to unfavorable…”
Matrix Metalloproteinases: From Structure to Function
Fragai, M., & Luchinat, C. (2015) · Wiley eBooks · doi:10.1002/9781118772287.ch3 · Cited by 1
Skagseth, S. (2017) · NORA - Norwegian Open Research Archives
Kinetic, mechanistic, structural and spectroscopic investigations of Bimetallic Metallohydrolases
Selleck, C. (2017) · The University of Queensland · doi:10.14264/uql.2017.1053
Au, S. X., & Normi, Y. M. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100503
BindingDB (2022) · UC San Diego · doi:10.7270/q2qz2fm0
BindingDB Entry 50015641: Recent research and development of NDM-1 inhibitors.
BindingDB (2023) · UC San Diego · doi:10.7270/q2b85d27
Metadata
- Authors
- Docquier, J.-D., Benvenuti, M., Calderone, V., Stoczko, M., Menciassi, N., Rossolini, G. M., & Mangani, S.
- Affiliations
- University of Siena (IT)
- Dipartimento di Biologia Molecolare, Laboratorio di Fisiologia e Biotecnologia dei Microrganismi, Università di Siena, I-53100 Siena, Italy
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2010-10
- Volume
- 54
- Issue
- 10
- Pages
- 4343-4351
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2944595
- OpenAlex
- W2016662547
- Cited by
- 51
- References
- 58
- Citations by year
- 2026: 1 · 2025: 3 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 5 · 2019: 1 · 2018: 6 · 2017: 4 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 3 · 2012: 7
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- ORBi (University of Liège) (submittedVersion)
- Use Siena air (University of Siena) (submittedVersion)
- Funders
- European Synchrotron Radiation Facility
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
- Keywords
- metallo-beta-lactamase, Bradyrhizobium japonicum, crystal structure, substrate specificity, active site loop, beta-lactam resistance, structure-function relationship
- MeSH terms
- beta-Lactamases, Molecular Sequence Data, Substrate Specificity, Sulfonamides, Protein Structure, Secondary, Crystallography, X-Ray, Bradyrhizobium
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.